Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
1.710
+0.015 (0.88%)
At close: May 30, 2025, 4:00 PM
1.800
+0.090 (5.26%)
Pre-market: Jun 2, 2025, 8:43 AM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $61.54 million as of June 2, 2025. Its market cap has increased by 29.70% in one year.
Market Cap
61.54M
Enterprise Value
29.75M
1-Year Change
29.70%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $61.54M, a decrease of -83.18%. That is a compound annual growth rate of -37.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 61.54M | -9.92% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |